Smartleaf Asset Management »

Bicara Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.4k 274 16.12

More positions owned by Smartleaf Asset Management

Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Smartleaf Asset Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
State Street Corporation
Franklin Resources
Blackstone Group
Millennium Management

View all funds holding Bicara Therapeutics